https://www.marketscreener.com/quote/stock/HEARTWARE-INTERNATIONAL-I-5104162/news/HeartWare-Completes-Enrollment-In-ENDURANCE2-Supplemental-Destination-Therapy-Trial-20838294/?utm_source=telegram&utm_medium=social&utm_campaign=share